Desensitization to Adalimumab: An Example of Repeated Desensitization to a Biological Agent

Biological agents seem to have been more effective than classic immunosuppressive drugs; however, the adverse events including the hypersensitivity reactions are the main drawbacks of these drugs. We report a 35-year-old man who was treated with adalimumab for ankylosing spondylitis, had a local rea...

Descripción completa

Detalles Bibliográficos
Autores principales: Demirel, Fevzi, Kartal, Ozgur, Gulec, Mustafa, Yesillik, Sait, Baysan, Abdullah, Tezel, Kutay, Musabak, Ugur, Sener, Osman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5005775/
https://www.ncbi.nlm.nih.gov/pubmed/27747718
http://dx.doi.org/10.1007/s40800-015-0008-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5005775/
https://www.ncbi.nlm.nih.gov/pubmed/27747718
http://dx.doi.org/10.1007/s40800-015-0008-2

Ejemplares similares